期刊文献+

临床常见革兰阴性细菌的分布及耐药性分析 被引量:12

The distribution and drug resistance analysis of common gram-negative bacterium in clinic
下载PDF
导出
摘要 目的了解院内革兰阴性细菌的分布及耐药性特点。方法收集本院2004年7月~2006年7月各类临床标本分离出的革兰阴性细菌,采用K-B纸片琼脂扩散法进行药敏试验,分析其临床分布及耐药性。结果共分离出1271株革兰阴性细菌,以大肠埃希菌、克雷伯菌属和铜绿假单胞菌为主要病原菌,标本主要分布于痰、咽拭子和尿液中,病区主要集中于ICU室、神经外科和肺科。超广谱β-内酰胺酶(ESBLs)在大肠埃希菌、克雷伯菌属和变形杆菌属的检出率分别为38.4%、31.7%和25.5%。亚胺培南和美罗培南对肠杆菌科细菌、产ESBLs菌株和不动杆菌属的抗菌活性最强,耐药率为0-5.6%,铜绿假单胞菌对两药的耐药率为29.8%和27.2%;嗜麦芽窄食单胞菌对两药物高度耐受,耐药率均为95.7%,但对环丙沙星、头孢哌酮/舒巴坦和替卡西林/克拉维酸较敏感。结论大肠埃希菌、克雷伯菌属和铜绿假单胞菌为本院最常见革兰阴性细菌,亚胺培南和美罗培南对除嗜麦芽窄食单胞菌外的其他革兰阴性细菌具有较好的抗菌活性,其他抗菌药物的抗菌活性相对较低。 Objective To investigate the distribution and drug resistance of gram-negative bacterium in our hospital. Methods Antimicrobial susceptibility of gram-negative bacterium isolated in various kinds of specimens from July 2004 to July 2006 was tested by kirby bauer method. The ditribution and drug resistance were analyzed. Results There were mainly Escherichia coli, Klebsiella spp and Pseudomonas aeuroginosa among 1 271 gram-negative bacterium isolated in two years. The distribution of specimens came mainly from sputum, respiratory secretions and urine. They were gathered from ICU, neurosurgery and pulmonary disease ward. The detection rates of extended spectrum beta-lactamases(ESBLs) producing E. coli, Klebsiella spp and Proteus spp were 38.4%, 31.7% and 25. 5%, respectively. Enterobacteriaceae spp, ESBLs producing strains and Acinetobacter spp were most susceptible to imipenem and meropenem, and the resist- ant rates were from 0 to 5.6%, but those of P. aeuroginosa were 29.8% and 27.2%, respectively. Both the resistant rates of S. maltophilia to imipenem and meropenem were 95.7%, but Stenotrophomonas maltophilia was susceptible to ciprofloxacin, cefoperazone/sulbactam and ticarcillin/clavulanic acid. Conclusion There are mainly E. coli, Klebsiella spp and P. aeuroginosa among gram-negative bacterium in our hospital. Imipenem and meropenem remain highly active against gram-negative bacterium except S. maltophilia. Other antimicrobial agents are less active.
出处 《中国病原生物学杂志》 CSCD 2008年第7期481-484,共4页 Journal of Pathogen Biology
基金 国家自然科学基金项目(No30400373)
关键词 革兰阴性细菌 超广谱β-内酰胺酶(ESBLs) 耐药性 Gram negative bacterium extended spectrum beta-lactamases(ESBLs) drug resistance
  • 相关文献

参考文献12

  • 1李宗清,崔颖鹏,陈求刚,陈冬梅,禤建美,曾燕,廖康.常见革兰阴性杆菌的分布及耐药性分析[J].中国微生态学杂志,2006,18(1):71-72. 被引量:12
  • 2Kadi M, Aghrouch M, Seffar M, et al. Prevalence of Acinetobatter baumaii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-beta-lactamase[J].Med Mal Infect, 2006, 36(7):386-389.
  • 3Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing, fifteenth informational supplement[S]. 2005. M100-S15.
  • 4Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter[J].Trends Microbiol, 2006,14(9) :413-420.
  • 5张卓然,倪语星.临床微生物学和微生物检验[M].第3版.北京:人民卫生出版社,2004.503-506.
  • 6Munday CJ, Xiong J, Li C, et al. Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China[J]. Int J Antimicrob Agents, 2004,23(2):175-180.
  • 7杜敏,陈旭,马尚柱,马集云,张淑兰,杨启文,徐英春.新疆地区大肠埃希菌和克雷伯菌中产超广谱β-内酰胺酶基因型的研究[J].中华医院感染学杂志,2006,16(4):361-364. 被引量:22
  • 8Bonomo RA, Szabo D. Mechanisms of muhidrug resistance in Acinetobacter species and Pseudornonas aeruginosa[J].Clin Infect Dis, 2006,43 (2):S49-56.
  • 9McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum[J].Am J Infect Control, 2006, 34(5 Suppl 1):S29-37,S64-73.
  • 10Carvalho AP, Albano RM, de Oliveira DN, et al. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil[J]. Microb Drug Resist, 2006, 12(2): 103-108.

二级参考文献17

共引文献46

同被引文献115

引证文献12

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部